文献速递造血干细胞移植与细胞治疗贫血与红细胞疾病

骨髓衰竭患者无关供者造血细胞移植后供者端粒长度与死亡原因的关系

Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure.
PubMed 文献 · Blood · 2018-04-09

本研究利用国际血液与骨髓移植研究中心数据库和生物样本库,对1988至2004年间接受无关供者造血细胞移植的197例重型再生障碍性贫血患者进行分析,采用流式细胞术和荧光原位杂交测量供者淋巴细胞及亚群端粒长度,竞争风险生存回归分析死因特异性死亡。结果显示供者各细胞亚群端粒较长与全因死亡风险较低相关,B细胞端粒较长与感染相关死亡风险较低相关。

要点

  • 供者所有细胞亚群端粒较长均与全因死亡风险较低相关(P < .01)。
  • 供者B细胞端粒较长与感染相关死亡风险较低相关(HR 0.63,95%CI 0.46-0.87,P = .006)。
  • 供者端粒长度与移植物抗宿主病或植入失败所致死亡无统计学显著关联(P > .05)。

核心结论

  • 供者端粒较长与重型再生障碍性贫血患者无关供者造血细胞移植后感染相关死亡发生率降低相关。

研究设计与样本

  • 研究纳入1988年至2004年间接受无关供者造血细胞移植的重型再生障碍性贫血患者197例,中位移植年龄15岁(范围0.5-40岁),中位随访5年(范围<1个月至20.7年)。
  • 采用流式细胞术和荧光原位杂交测量供者总淋巴细胞及亚群(初始富集T细胞CD45RA+CD20-、记忆富集T细胞CD45RA-CD20-、NK完全分化T细胞CD45RA+CD57+、B细胞CD45RA+CD20+)的端粒长度,并使用竞争风险生存回归进行死因特异性死亡分析。
  • 临床数据和生物样本来自国际血液与骨髓移植研究中心数据库和生物样本库。

主要发现

  • 供者所有细胞亚群端粒较长均与全因死亡风险较低相关(P < .01)。
  • 供者B细胞端粒较长与感染相关死亡风险较低相关(HR 0.63,95%CI 0.46-0.87,P = .006);NK完全分化T细胞端粒较长可能与感染相关死亡风险较低相关(HR 0.7,95%CI 0.51-0.97,P = .03)。
  • 供者其他受测淋巴细胞亚群端粒长度与移植物抗宿主病或植入失败所致死亡无统计学显著关联(P > .05)。
  • 观察到移植物抗宿主病死亡风险增加的趋势(总淋巴细胞端粒长度HR 1.26,P = .15)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Previous studies have suggested that longer donor leukocyte telomere length (TL) is associated with improved survival after hematopoietic cell transplantation (HCT) in severe aplastic anemia (SAA). This study aimed to determine whether cell-specific lymphocyte TL is associated with certain post-HCT causes of death. We used flow cytometry and fluorescence in situ hybridization to measure TL in donor total lymphocytes and subsets: naïve enriched T cells (CD45RA+CD20-), memory enriched T cells (CD45RA-CD20-), natural killer (NK) fully differentiated T cells (CD45RA+CD57+), and B cells (CD45RA+CD20+). Competing risk survival regression was used for cause-specific death analyses. Clinical data and biospecimens were available from the Center for International Blood and Marrow Transplant Research database and biorepository. The study included 197 patients who underwent unrelated-donor HCT for SAA between 1988 and 2004. The median age at HCT was 15 years (range, 0.5-40 years), and the median follow-up was 5 years (range, <1 month to 20.7 years). Longer donor TL in all cell subsets was associated with lower risk of all-cause mortality (P < .01). In cause-specific mortality analyses, longer TL in B cells (hazard ratio [HR], 0.63; 95% confidence interval [CI], 0.46-0.87; P = .006) and possibly NK fully differentiated T cells (HR, 0.7; 95% CI, 0.51 to 0.97; P = .03) was associated with lower risk of infection-related death. Donor TL in other tested lymphocyte subsets was not statistically significantly associated with death resulting from graft-versus-host disease or graft failure (P > .05). However, a trend toward excess risk of graft-versus-host mortality was noted (HR for total lymphocyte TL, 1.26; P = .15). In conclusion, longer donor TL was associated with reduced rate of infection-related deaths after HCT for SAA.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Gadalla SM, Aubert G, Wang T, et al. Donor telomere length and causes of death after unrelated hematopoietic cell transplantation in patients with marrow failure. Blood. 2018. PMID: 29632022. doi:10.1182/blood-2017-10-812735

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。